410 ILCS 707/15: Cannabinoid lists.

(This Section may contain text from a Public Act with a delayed effective date)

(a) The following lists shall be used to determine what is hemp and what products qualify as a final consumer hemp cannabinoid product under this Act:

(1) Cannabinoids that are considered capable of being naturally produced by a Cannabis sativa L. plant:

(A) Cannabigerol (CBG), which includes, but is not limited to:

(i) CBGA (Cannabigerolic acid);

(ii) CBG (Cannabigerol);

(iii) CBGVA (Cannabigerovarinic acid);

(iv) CBGV (Cannabigerovarin);

(B) Cannabidiol (CBD), which includes, but is not limited to:

(i) CBDA (Cannabidiolic acid);

(ii) CBD (Cannabidiol);

(iii) CBDVA (Cannabidivarinic acid);

(iv) CBDV (Cannabidivarin);

(C) Delta 9-Tetrahydrocannabinol (THC), which includes, but is not limited to:

(i) THCA (Delta 9-Tetrahydrocannabinolic acid);

(ii) Delta 9-THC (Delta 9-Tetrahydrocannabinol);

(iii) THCVA (Tetrahydrocannabivarinic acid);

(iv) THCV (Tetrahydrocannabivarin);

(v) THCP (Tetrahydrocannabiphorol);

(D) Cannabichromene (CBC), which includes, but is not limited to:

(i) CBCA (Cannabichromenic acid);

(ii) CBC (Cannabichromene);

(iii) CBCVA (Cannabichromevarinic acid);

(iv) CBCV (Cannabichromevarin);

(E) Natural degradation and artifact subclasses, which include, but are not limited to:

(i) CBN (Cannabinol);

(ii) CBNA (Cannabinolic acid);

(iii) CBLA (Cannabicyclolic acid);

(iv) CBL (Cannabicyclol);

(v) CBE (Cannabielsoin);

(vi) CBT (Cannabitriol);

(vii) HHC (Hexahydrocannabinol);

(F) Minor natural isomers and trace compounds, which include, but are not limited to:

(i) Delta-8 THC (Delta 8-Tetrahydrocannabinol);

(ii) Delta-10 THC (Delta 10-Tetrahydrocannabinol);

(iii) exo-THC (Delta 9,11-Tetrahydrocannabinol);

(iv) THCA (Tetrahydrocannabinolic acid);

(v) THC-C1 (Tetrahydrocannabiorcol); and

(G) All cannabinoids that appear on a list of cannabinoids that are known to the federal Food and Drug Administration to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature, and that is published by the federal Food and Drug Administration pursuant to 7 U.S.C. 1639o.

(2) Cannabinoids that are tetrahydrocannabinol class cannabinoids known to be naturally occurring in the Cannabis sativa L. plant:

(A) THCA (Delta 9-Tetrahydrocannabinolic acid);

(B) THC (Delta 9-Tetrahydrocannabinol);

(C) THCV (Tetrahydrocannabivarin);

(D) THCVA (Tetrahydrocannabivarin acid);

(E) THCP (Tetrahydrocannabiphorol); and

(F) All tetrahydrocannabinol class cannabinoids that appear on a list of tetrahydrocannabinol class cannabinoids that are known to the federal Food and Drug Administration to be naturally occurring in the Cannabis sativa L. plant and that are published by the federal Food and Drug Administration pursuant to 7 U.S.C. 1639o.

(3) Cannabinoids that are known to have similar effects to, or marketed to have similar effects to, tetrahydrocannabinol class cannabinoids:

(A) Delta-5 THC (Delta-5 tetrahydrocannabinol);

(B) Delta-6 THC (Delta-6 tetrahydrocannabinol);

(C) Delta-7 THC (Delta 7-Tetrahydrocannabinol);

(D) Delta-8 THC (Delta 8-Tetrahydrocannabinol);

(E) Delta-10 THC (Delta 10-Tetrahydrocannabinol);

(F) Delta-6a10a THC (often sold as Delta-3 THC);

(G) Delta 10a THC (Delta 10-Tetrahydrocannabinol acid);

(H) Delta-11 THC (Delta-11tetrahydrocannabinol)

(I) HHC (Hexahydrocannabinol);

(J) HHCP (Hexahydrocannabiphorol);

(K) HHCH (Hexahydrocannabihexol);

(L) exo-THC (Delta 9,11-Tetrahydrocannabinol);

(M) THCP (Tetrahydrocannabiphorol);

(N) THCB (Tetrahydrocannabutol);

(O) THCH (Tetrahydrocannabihexol);

(P) THC-O-Acetate (Delta-9-Tetrahydrocannabinol acetate, THC-O/ATHC);

(Q) HHC-O-Acetate (Hexahydrocannabinol O acetate, HHC-O);

(R) THCP-O (Delta-9-Tetrahydrocannabiphorol-O-acetate);

(S) THCJD (Tetrahydrocannabioctyl); and

(T) All tetrahydrocannabinol class cannabinoids that appear on a list of cannabinoids that are known to the federal Food and Drug Administration to have similar effects to, or marketed to have similar effects to, tetrahydrocannabinol class cannabinoids and that is published by the federal Food and Drug Administration pursuant to 7 U.S.C. 1639o.

(b) The Department, by rule, may add, change, or remove any of the items included in the lists established in this Section.

(c) The Department shall publish any updates to the list, including any federal additions, on its website.